» Articles » PMID: 16973906

Protein Kinase A-mediated Acceleration of the Stretch Activation Response in Murine Skinned Myocardium is Eliminated by Ablation of CMyBP-C

Overview
Journal Circ Res
Date 2006 Sep 16
PMID 16973906
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Beta-adrenergic agonists induce protein kinase A (PKA) phosphorylation of the cardiac myofilament proteins myosin binding protein C (cMyBP-C) and troponin I (cTnI), resulting in enhanced systolic function, but the relative contributions of cMyBP-C and cTnI to augmented contractility are not known. To investigate possible roles of cMyBP-C in this response, we examined the effects of PKA treatment on the rate of force redevelopment and the stretch activation response in skinned ventricular myocardium from both wild-type (WT) and cMyBP-C null (cMyBP-C(-/-)) myocardium. In WT myocardium, PKA treatment accelerated the rate of force redevelopment and the stretch activation response, resulting in a shorter time to the peak of delayed force development when the muscle was stretched to a new isometric length. Ablation of cMyBP-C accelerated the rate of force redevelopment and stretch activation response to a degree similar to that observed in PKA treatment of WT myocardium; however, PKA treatment had no effect on the rate of force development and the stretch activation response in null myocardium. These results indicate that ablation of cMyBP-C and PKA treatment of WT myocardium have similar effects on cross-bridge cycling kinetics and suggest that PKA phosphorylation of cMyBP-C accelerates the rate of force generation and thereby contributes to the accelerated twitch kinetics observed in living myocardium during beta-adrenergic stimulation.

Citing Articles

Modeling the effects of thin filament near-neighbor cooperative interactions in mammalian myocardium.

Phan T, Fitzsimons D J Gen Physiol. 2025; 157(2).

PMID: 39869069 PMC: 11771317. DOI: 10.1085/jgp.202413582.


A gradient of force generation at rest differentiates cardiomyopathy outcomes with variants of actin located at the same residue.

Jones M, Tran C, Singh J, Dawson J J Mol Cell Cardiol Plus. 2025; 2():100023.

PMID: 39802493 PMC: 11708414. DOI: 10.1016/j.jmccpl.2022.100023.


Mechanism-based myofilament manipulation to treat diastolic dysfunction in HFpEF.

Dominic K, Schmidt A, Granzier H, Campbell K, Stelzer J Front Physiol. 2024; 15:1512550.

PMID: 39726859 PMC: 11669688. DOI: 10.3389/fphys.2024.1512550.


The D75N and P161S Mutations in the C0-C2 Fragment of cMyBP-C Associated with Hypertrophic Cardiomyopathy Disturb the Thin Filament Activation, Nucleotide Exchange in Myosin, and Actin-Myosin Interaction.

Kochurova A, Beldiia E, Nefedova V, Yampolskaya D, Koubassova N, Kleymenov S Int J Mol Sci. 2024; 25(20).

PMID: 39456977 PMC: 11508426. DOI: 10.3390/ijms252011195.


Alterations in cardiac contractile and regulatory proteins contribute to age-related cardiac dysfunction in male rats.

Han Y, Pakkam M, Fogarty M, Sieck G, Brozovich F Physiol Rep. 2024; 12(16):e70012.

PMID: 39169429 PMC: 11338742. DOI: 10.14814/phy2.70012.